Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Pergolide is a potent dopamine D1 and D2 receptor agonist (Kis = 111 and 0.495 nM, respectively, for rat striatal receptors).1 It depresses dopaminergic firing in paralyzed rats (ED50 = <20 μg/kg), an effect that can be reversed by the dopamine D2-selective antagonist spiperone or the dopamine D1-selective antagonist SCH 23390 (Item No. 15631).2 Pergolide (0.025 and 0.05 mg/kg) increases the volume threshold for inducing bladder contraction in a cynomolgus monkey model of Parkinson's disease induced by MPTP.3 It also reduces carrageenan-induced paw edema in adrenalectomized rats (ED50 = 0.4 mg/kg).4
WARNING This product is not for human or veterinary use.
1. Dopamine receptor affinities in vitro and stereotypic activities in vivo of cabergoline in rats. Biol. Pharm. Bull. 19(9), 1210-1213 (1996).
2. Agonistic actions of pergolide on firing activity of dopamine neurons in substantia nigra compacta area. Zhongguo Yao Li Xue Bao. 16(5), 423-427 (1995).
3. Therapeutic effects of dopamine D1/D2 receptor agonists on detrusor hyperreflexia in 1-
4. Anti-